Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT03564093
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients aged 1-12 years at the Oulu University Hospital emergency room who would benefit from sedative medication during small painful procedures like i.v. cannulation or lumbar puncture are asked to take part in our study
Exclusion Criteria:
* Allergy to dexmedetomidine or any supplementary elements of the Dexdor®-solution
* II or III degree AV-blockage without pacemaker
* Uncontrollable hypotension
* Stroke
* Critically ill patients who are admitted to the PICU
* Patients with clear cardiac or respiratory dysfunction
* Lowered level of consciousness
* Patients with increased risk of apnoeic events due to neurologic or metabolic conditions or extreme obesity
* A single patient can only take part in this study once.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
12 Years
Study:
NCT03564093
Study Brief:
Protocol Section:
NCT03564093